![]() |
市场调查报告书
商品编码
1828140
2025年全球腹腔镜设备市场报告Laparoscopy Devices Global Market Report 2025 |
近年来,腹腔镜器械市场呈现强劲成长势头,市场规模从2024年的127.5亿美元成长至2025年的134.9亿美元,复合年增长率为5.8%。预测期内的成长可归因于外科医生培训计画的改进、安全性和有效性的提高、向微创手术的转变、能量器械的演变以及早期应用的挑战。
预计未来几年腹腔镜设备市场规模将强劲成长,到2029年将达到183.9亿美元,复合年增长率为8.1%。预测期内的成长可归因于客製化和以患者为中心的理念、新兴国家的市场渗透、培训和技能发展项目、机器人辅助系统的整合以及能源型设备的成长。预测期内的主要趋势包括设备小型化、微创手术的兴起、新兴国家的采用、对培训和教育的重视以及机器人技术的整合。
腹腔镜设备由带有伸缩桿透镜系统的硬式内视镜组成,通常连接到单头或三头摄影机。这些设备使外科医生无需进行大面积皮肤切口即可进入腹部和骨盆区域。
腹腔镜器械的主要类型包括腹腔镜、能量器械、气腹器械、机器人辅助手术系统、吸引或冲洗系统、闭合器械、手持器械、介入性器械及其配件。例如,腹腔镜是一种小型管状医疗设备,配有照明灯、镜头和用于组织切除的工具。它可用于各种外科手术,例如一般外科、减重手术和妇科手术,并被包括医院和诊所在内的各种终端用户使用。
2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供腹腔镜设备市场统计数据,包括全球市场规模、区域份额、腹腔镜设备市场份额竞争对手、详细的腹腔镜设备细分市场、市场趋势和商机,以及您在腹腔镜设备行业取得成功所需的数据。本腹腔镜设备市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
未来五年8.1%的预测成长率比我们先前对该市场的预测略有下降,下降了0.2%。下降的主要原因是美国与其他国家之间关税的影响。这种影响可能会直接波及美国,导致5毫米套管针组件和高清摄影机成像晶片的供应链中断,这些组件来自法国和以色列等关键地区,这可能导致微创手术的延误和腹部手术成本的增加。由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响,这种影响也可能更为广泛。
慢性病盛行率的上升预计将推动未来腹腔镜设备市场的扩张。慢性病的特征是持续一年以上、需要持续治疗且常常限制日常活动的健康问题。这类疾病的例子包括心臟病、癌症、肥胖和糖尿病。腹腔镜检查可以为患有未确诊的慢性腹痛的患者提供准确的诊断和治疗性介入。此外,研究表明,这些设备有助于微创外科手术。根据美国心臟学会 2022 年 8 月发布的报告,预计 2025 年至 2060 年间美国所有四大心血管危险因子都将增加。预计增幅最大的是糖尿病,增加 39.3% 至 5,500 万人,其次是血脂异常症(增加 27.6% 至 1.26 亿人)、高血压(增加 25.1% 至 1.62 亿人)和肥胖(增加 18.3% 至 1.26 亿人)。此外,心血管疾病患者数量预计将大幅增加,包括中风(增加33.8%,达到1500万人)和心臟衰竭(增加33.4%,达到1300万人)。缺血性心臟疾病(成长30.7%,达2,900万人)和心臟病发作(成长16.9%,达1,600万人)也将大幅增加。因此,慢性病盛行率的上升将成为腹腔镜设备市场成长的关键因素。
由于肥胖症的日益普遍,腹腔镜设备市场也预计将成长。肥胖症是指体内脂肪堆积过多,身体质量指数 (BMI) 达到或超过 30,会对健康造成重大风险。腹腔镜设备通常用于肥胖患者的微创手术,可减少术后併发症并加速復原速度。截至 2022 年 3 月,世界卫生组织 (WHO) 报告称,肥胖影响了超过 10 亿人,其中包括 6.5 亿成年人、3.4 亿青少年和 3,900 万名儿童。预计这一数字将继续增长,到 2025 年,估计将有 1.67 亿人因超重或肥胖而健康状况不佳。因此,肥胖症的日益普遍推动了腹腔镜设备市场的发展。
腹腔镜设备市场的主要企业正致力于开发先进的能量系统,以改善手术效果并提高手术效率。这些创新的能量设备融合了最尖端科技和多功能性,对于腹腔镜手术至关重要。例如,2022 年 9 月,致力于创造疾病检测、预防和治疗解决方案的日本医疗技术公司Olympus Corporation推出了专为开放手术设计的手术能量设备 THUNDERBEAT 开放性手术 Jaw Type X。该设备将先进的能量输送与精确的组织操作相结合,以促进有效的解剖和凝固。其设计最大限度地减少了热量扩散,同时提高了手术效率,使其在精度和控制是成功关键的腹腔镜手术中特别有用。
腹腔镜设备市场的主要企业正专注于开发先进的视觉化系统,以提高手术精度并改善临床效果。高清影像解决方案,尤其是将3D视觉化与直觉功能结合的解决方案,对于腹腔镜手术至关重要。例如,2023年5月,德国医疗保健公司B.Braun推出了AESCULAP EinsteinVision 3.0 FI系统。该系统透过先进的3D萤光成像功能改进了腹腔镜手术,可即时可视化血管和胆管等关键结构。内建防雾技术可确保手术过程中的清晰视野,多种萤光迭加模式可灵活评估组织灌注和解剖结构。透过促进微创干预过程中的精确导航和决策,该系统显着缩短了手术时间并改善了手术效果。
2023年6月,总部位于爱尔兰、专注于感染预防、消毒和外科产品的STERIS plc公司以5.4亿美元收购了Becton, Dickinson & Co.的外科器械资产。此次收购增强了STERIS的外科解决方案组合,尤其专注于扩大其高品质外科器械的选择范围,以满足医疗专业人士的需求。 Becton, Dickinson & Co.是一家总部位于美国的腹腔镜设备供应商。
腹腔镜设备市场的主要企业包括 B. Braun Melsungen AG、Boston Scientific Corporation、CONMED Corporation、Ethicon Inc.、Karl Storz SE &Co.KG、Medtronic PLC、Olympus Corporation、Richard Wolf GmbH、Smith & Nephew PLC、Stryker Corporation、Intuitive Surgical Corporation Inc.、The Cooperm. Ltd.、Applied Medical Resources Corporation、Cooper Surgical Inc、 FUJIFILM Holdings Corporation、Grena Ltd.、Henke-Sass Wolf GmbH、LaproSurge Ltd.、Maxer Endoscopy GmbH、MedGyn Products Inc.、EndoOptiks Inc.、EndoChoice Inc.、Endo-TechTech W. Glence G LiNA Medical ApS。
2024年,北美是腹腔镜设备市场最大的地区。根据全球腹腔镜设备市场报告,预计亚太地区将在预测期内成为成长最快的地区。腹腔镜设备市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。
腹腔镜设备市场报告涵盖的国家包括澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙
腹腔镜设备市场包括腹腔镜剪、抓取器、针柄、分离器和牵开器的销售。该市场的价值为“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的商品价值。该市场商品的价值还包括商品製造商销售的任何相关服务。
Laparoscopy devices are comprised of rigid endoscopes equipped with telescopic rod lens systems, typically connected to single-chip or three-chip video cameras. These devices enable surgeons to access the abdominal and pelvic regions without the need for significant skin incisions.
The primary types of laparoscopy devices include laparoscopes, energy devices, insufflators, robot-assisted surgery systems, suction or irrigation systems, closure devices, hand instruments, access devices, accessories, and others. Laparoscopes, for instance, are small, tube-shaped medical devices featuring a light, a lens, and an instrument for tissue removal. They find applications in various surgical procedures, including general surgery, bariatric surgery, and gynecological surgery, and are utilized by diverse end users such as hospitals, clinics, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The laparoscopy devices market research report is one of a series of new reports from The Business Research Company that provides laparoscopy devices market statistics, including laparoscopy devices industry global market size, regional shares, competitors with a laparoscopy devices market share, detailed laparoscopy devices market segments, market trends and opportunities, and any further data you may need to thrive in the laparoscopy devices industry. This laparoscopy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The laparoscopy devices market size has grown strongly in recent years. It will grow from $12.75 billion in 2024 to $13.49 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to improved surgeon training programs, enhanced safety and efficacy, shift towards minimally invasive surgery, evolution in energy-based devices, early adoption challenges.
The laparoscopy devices market size is expected to see strong growth in the next few years. It will grow to $18.39 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to customization and patient-centric approach, market penetration in emerging economies, training and skill enhancement programs, integration of robotic-assisted systems, growth in energy-based devices. Major trends in the forecast period include miniaturization of devices, rise in minimally invasive surgeries, adoption in emerging economies, focus on training and education, integration of robotics.
The forecast of 8.1% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for 5mm trocar assemblies and high definition (HD) camera imaging chips, sourced from key regions such as France and Israel, which could lead to delayed minimally invasive surgeries and increased costs for abdominal procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of chronic diseases is projected to drive the expansion of the laparoscopy devices market in the future. Chronic diseases are characterized as health issues that persist for a year or more, requiring ongoing medical treatment and often limiting daily activities. Examples of such diseases include heart disease, cancer, obesity, and diabetes. Laparoscopy can provide patients suffering from undiagnosed chronic abdominal pain with accurate diagnoses and therapeutic interventions. Additionally, research indicates that these devices facilitate minimally invasive surgical techniques. A report released by the American College of Cardiology in August 2022 highlighted that all four major cardiovascular risk factors in the United States are expected to rise between 2025 and 2060. The most significant increase is anticipated in diabetes, with a 39.3% rise to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Furthermore, notable increases in cardiovascular disease rates are expected, including a 33.8% rise in stroke cases (up to 15 million) and a 33.4% increase in heart failure (up to 13 million). Ischemic heart disease (up 30.7% to 29 million) and heart attack (up 16.9% to 16 million) will also see significant growth. Consequently, the rising prevalence of chronic diseases is a key factor in the growth of the laparoscopy devices market.
The laparoscopy devices market is also set to grow owing to the increasing prevalence of obesity. Obesity, a condition marked by excessive body fat accumulation and defined by a body mass index (BMI) of 30 or higher, poses significant health risks. Laparoscopy devices are commonly employed in minimally invasive surgical procedures for obese individuals, resulting in reduced postoperative complications and faster recovery. As of March 2022, the World Health Organization reported that over 1 billion people globally, including 650 million adults, 340 million adolescents, and 39 million children, were affected by obesity. This number continues to rise, with an estimated 167 million people experiencing deteriorating health due to being overweight or obese by 2025. Hence, the laparoscopy devices market is propelled by the increasing prevalence of obesity.
Leading companies in the laparoscopy devices market are focused on developing advanced energy systems to improve surgical outcomes and enhance procedural efficiency. These innovative energy devices, which integrate state-of-the-art technology with versatility, are essential for laparoscopic surgeries. For example, in September 2022, Olympus Corporation, a Japanese medical technology firm dedicated to creating solutions for disease detection, prevention, and treatment, introduced the THUNDERBEAT Open Fine Jaw Type X surgical energy devices designed for open surgery. This device combines advanced energy delivery with precise tissue manipulation, facilitating effective dissection and coagulation. Its design enhances surgical efficiency while minimizing thermal spread, making it especially valuable in laparoscopic procedures, where precision and control are critical for achieving successful results.
Prominent companies in the laparoscopy devices market are focusing on the development of advanced visualization systems to boost surgical precision and enhance clinical outcomes. High-definition imaging solutions, particularly those that combine 3D visualization with intuitive features, are essential for laparoscopic procedures. For example, in May 2023, B. Braun, a healthcare company based in Germany, introduced the AESCULAP EinsteinVision 3.0 FI system. This system improves laparoscopic surgeries through its advanced 3D fluorescence imaging capabilities, enabling real-time visualization of critical structures like blood vessels and bile ducts. Its built-in anti-fog technology ensures a clear view throughout the procedure, while various fluorescence overlay modes offer flexibility in assessing tissue perfusion and anatomy. By facilitating accurate navigation and decision-making during minimally invasive interventions, this system significantly reduces operating times and enhances surgical outcomes.
In June 2023, STERIS plc, an Ireland-based provider specializing in infection prevention, decontamination, and surgical products, completed the acquisition of surgical instrumentation assets from Becton, Dickinson, and Company for $540 million. This acquisition was intended to enhance STERIS's portfolio in surgical solutions, with a particular emphasis on broadening its selection of high-quality surgical instruments to better meet the needs of healthcare providers. Becton, Dickinson, and Company is a US-based company that supplies laparoscopy devices.
Major companies operating in the laparoscopy devices market include B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, Ethicon Inc., Karl Storz SE & Co. KG, Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew PLC, Stryker Corporation, Intuitive Surgical Inc., The Cooper Companies Inc., Microline Surgical Inc., Becton Dickinson and Company, Welfare Medical Ltd., Applied Medical Resources Corporation, Cooper Surgical Inc., Fujifilm Holdings Corporation, Grena Ltd., Henke-Sass Wolf GmbH, LaproSurge Ltd., Maxer Endoscopy GmbH, MedGyn Products Inc., EndoOptiks Inc., EndoChoice Inc., Endo-Technik W. Griesat GmbH, Endo-Flex GmbH, Endo-Therapeutics Inc., Smiths Group plc, LiNA Medical ApS
North America was the largest region in the laparoscopy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global laparoscopy devices market report during the forecast period. The regions covered in the laparoscopy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the laparoscopy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The laparoscopy devices market consists of sales of laparoscopic scissors, graspers, needle handles, dissectors, and retractors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Laparoscopy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on laparoscopy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for laparoscopy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The laparoscopy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.